An Experimental Generator for Production of High-Purity212Pb for Use in Radiopharmaceuticals
Authors:
Open Access
- 7 July 2022
- journal article
- research article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 64 (1) , 173-176
Abstract
The feasibility, performance, and radiation safety of an experimental generator were evaluated to efficiently produce 212Pb intended for radiopharmaceuticals. Methods: The generator consisted of a flask with a removable cap containing a source of 224Ra or 228Th absorbed on quartz wool. Gaseous 220Rn emanated from the decaying source, which subsequently decayed to 212Pb, which was adsorbed on the flask’s interior surface. The 212Pb was collected by washing the flask with 0.5–1 mL of 0.1 M HCl. Results: The generator collector flask trapped 62%–68% of the 212Pb, of which more than 87% (tested up to 26 MBq) could be harvested. The obtained 212Pb solution had a high purity (>99.98%) and could be used for the preparation of radioconjugates with more than 97% radiochemical purity. Future designs of the generator should aim to further reduce the risk of radon and γ-energy exposure to operators. Conclusion: The presented technology is a promising method for easy and convenient 212Pb production. Visual AbstractKeywords
This publication has 14 references indexed in Scilit:
- Physical and chemical processes on the 212Pb radionuclide production for nuclear medicineJournal of Physics: Conference Series, 2018
- Automated cassette-based production of high specific activity [ 203/212 Pb]peptide-based theranostic radiopharmaceuticals for image-guided radionuclide therapy for cancerApplied Radiation and Isotopes, 2017
- Preparation of 212 Pb-labeled monoclonal antibody using a novel 224 Ra-based generator solutionNuclear Medicine and Biology, 2017
- Application of 212Pb for Targeted α-particle Therapy (TAT): Pre-clinical and Mechanistic Understanding through to Clinical TranslationAIMS Medical Science, 2015
- Pharmacokinetics and Imaging of 212 Pb-TCMC-Trastuzumab After Intraperitoneal Administration in Ovarian Cancer PatientsCancer Biotherapy and Radiopharmaceuticals, 2014
- Methodology for labeling proteins and peptides with lead-212 (212Pb)Nuclear Medicine and Biology, 2013
- New Stochastic Annual Limits on Intake for Selected Radionuclides2009
- A 212Pb generator based on a 228Th sourceApplied Radiation and Isotopes, 2001
- A generator for production of 212Pb and 212BiApplied Radiation and Isotopes, 1994
- An improved generator for the production of 212Pb and 212Bi from 224RaApplied Radiation and Isotopes, 1988